Skip to Content

Vanderbilt-Ingram Cancer CenterVanderbilt-Ingram Cancer Center

 

E-Newsletter

  • Subscribe to our e-Newsletter to receive email updates:

  • Related Articles

    Most Recent

    Archives

    Join Us

    News: Cancer Research

    Lit up COX-2 cancer probe

    Friday, June 19th, 2015

    Visualizing tumors is crucial for proper diagnosis and treatment. Near-infrared (NIR) fluorescence is a promising optical imaging technique due to its sensitivity to specific disease-related molecules. Development of NIR probes that show only tumor and not non-tumor tissues, a common problem with current methods, would be invaluable. Reporting last month in the Journal of Biomedical […]

    New VU app takes SMART look at clinical information sharing

    Friday, June 5th, 2015

    On June 1 in Chicago, at the annual meeting of the American Society of Clinical Oncology, a mobile computer application under development at Vanderbilt University Medical Center, called SMART Precision Cancer Medicine (PCM), was featured in a demonstration of improved cancer care coordination through clinical data interoperability and electronic clinical information sharing. SMART (Substitutable Medical […]

    Exploring Accountable Care Organizations’ impact on cancer screenings

    Friday, May 29th, 2015

    As health care organizations implement new strategies to improve quality and reduce costs, a physician researcher at VUMC is setting out to identify whether there could be unintended effects. Matthew Resnick, M.D., MPH, assistant professor of Urologic Surgery and Health Policy, has been awarded a $726,000 grant from the American Cancer Society to study the […]

    Tools for exploring ‘omics’ data

    Thursday, May 21st, 2015

    Advances in technology have generated vast amounts of “omics” data: genomic, epigenomic, transcriptomic, proteomic and metabolomic changes for all types of specimens. Bridging the gap between data generation and investigators’ ability to retrieve and interpret data is essential to realize the biological and clinical value of this wealth of information. Bing Zhang, Ph.D., and colleagues […]

    VICC Annual Retreat focuses on immunotherapy

    Thursday, May 21st, 2015

    Cancer cells multiply, spread and thrive in large measure because the body’s immune system doesn’t recognize the cancer as a lethal threat. Efforts to enable the immune system to “see” the cancer and attack the aberrant cells were the prime focus during Vanderbilt-Ingram Cancer Center’s Annual Retreat, held April 30 at the Vanderbilt University Student […]

    Jansen’s cancer research efforts garner recognition

    Thursday, May 14th, 2015

    Valerie Malyvanh Jansen, M.D., Ph.D., a third-year medical oncology fellow, recently received several national awards and grants, as well as a Vanderbilt-Ingram Cancer Center fellowship, in recognition of her translational cancer research. Jansen received an American Association for Cancer Research (AACR) 2015 Women in Cancer Research Scholars Award. The awards are given to members of […]

    Supportive environment spurs Biomedical Sciences graduates

    Thursday, May 14th, 2015

    “It takes a village to raise a scientist.” That’s how Shenika Poindexter describes Vanderbilt University’s approach to graduate training in the biomedical sciences. “I had a lot of help,” said Poindexter, who celebrated her recently minted Ph.D. in Cancer Biology at the Graduate School’s Commencement ceremony last week. The support provided by faculty mentors and […]

    Discovery Lecture to feature VICC experts

    Thursday, May 14th, 2015

    Three Vanderbilt University scientists will describe “gene-environment interactions in cancer etiology and prevention” at 4 p.m. Thursday, May 21, in 208 Light Hall. The panel discussion of “cutting-edge discovery” at Vanderbilt is the final Flexner Discovery Lecture of the 2014-2015 academic year. Speakers include: • Robert J. Coffey Jr., M.D., Ingram Professor of Cancer Research, professor […]

    VICC research efforts in spotlight at AACR conference

    Thursday, April 30th, 2015

    Adding an investigational drug to an already approved estrogen blocking therapy appears to be safe and provided clinical benefit for some postmenopausal women with estrogen-positive breast cancer. The research led by Ingrid Mayer, M.D., associate professor of Medicine and clinical director of the Breast Cancer Program at Vanderbilt-Ingram Cancer Center (VICC), was selected for the […]

    Best hospital depends on cancer type

    Thursday, April 23rd, 2015

    The idea of a “Best Hospital for Cancer” does not reflect the fact that cancer comprises many different diseases. Jeffery Goldstein, M.D., Ph.D., a resident in the Department of Pathology, Microbiology and Immunology at Vanderbilt, and Vinay Prasad, M.D., MPH, aimed to rank the 50 highest ranked cancer hospitals – from the 2013 U.S. News […]

    Next Page »« Previous Page